Alkermes plc (NASDAQ: ALKS) completed its acquisition of Avadel Pharmaceuticals plc (NASDAQ: AVDL), adding the FDA-approved sleep disorder treatment LUMRYZ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE